Fix the Inflation Reduction Act for Seniors’ Health

Click here to read this Op-Ed on

It’s rare that a program covering more than 50 million individuals can achieve the popularity that Medicare Part D has achieved and maintained for over two decades now. This voluntary health benefit has impressively continued to appease America’s seniors who rely on it for prescription drug coverage. As the old saying goes, “Don’t fix what isn’t broken.” However, structural changes brought about by 2022’s Inflation Reduction Act (IRA) threaten this vital program’s success.

As we age, more and more health concerns can arise that need prompt treatment, which is why it’s so imperative that seniors’ Part D plans offer coverage of a variety of high-quality medications. If option one doesn’t work, for example, doctors should be able to prescribe beneficiaries option two or three to see if those treatments are more appropriate for their health conditions. However, the IRA will only fragment these care plans, as it has worsened their coverage options. With additional roadblocks to care, seniors could face worse outcomes for health conditions that should be manageable.

The IRA has changed a program that should be improving lives to one that will make it much more difficult for Americans to get better care. Before it’s too late, Congress must stand up for our aging population and ensure they get the medication and coverage they deserve.


Similar Posts